U.S. flag

An official website of the United States government

NM_020964.3(EPG5):c.2355del (p.Arg786fs) AND Vici syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Apr 6, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003064513.3

Allele description [Variation Report for NM_020964.3(EPG5):c.2355del (p.Arg786fs)]

NM_020964.3(EPG5):c.2355del (p.Arg786fs)

Gene:
EPG5:ectopic P-granules 5 autophagy tethering factor [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
18q21.1
Genomic location:
Preferred name:
NM_020964.3(EPG5):c.2355del (p.Arg786fs)
HGVS:
  • NC_000018.10:g.45930734del
  • NG_042838.1:g.41607del
  • NM_001410858.1:c.2354delC
  • NM_001410859.1:c.2354delC
  • NM_020964.3:c.2355delMANE SELECT
  • NP_001397787.1:p.Arg786Glufs
  • NP_001397788.1:p.Arg786Glufs
  • NP_066015.2:p.Arg786fs
  • LRG_1234t1:c.2355del
  • LRG_1234:g.41607del
  • LRG_1234p1:p.Arg786fs
  • NC_000018.9:g.43510699del
  • NC_000018.9:g.43510700del
Protein change:
R786fs
Molecular consequence:
  • NM_001410858.1:c.2354delC - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001410859.1:c.2354delC - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_020964.3:c.2355del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Vici syndrome (VICIS)
Synonyms:
Absent corpus callosum cataract immunodeficiency; Immunodeficiency with cleft lip/palate, cataract, hypopigmentation and absent corpus callosum
Identifiers:
MONDO: MONDO:0009452; MedGen: C1855772; Orphanet: 1493; OMIM: 242840

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003442589Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Apr 6, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy.

Byrne S, Jansen L, U-King-Im JM, Siddiqui A, Lidov HG, Bodi I, Smith L, Mein R, Cullup T, Dionisi-Vici C, Al-Gazali L, Al-Owain M, Bruwer Z, Al Thihli K, El-Garhy R, Flanigan KM, Manickam K, Zmuda E, Banks W, Gershoni-Baruch R, Mandel H, Dagan E, et al.

Brain. 2016 Mar;139(Pt 3):765-81. doi: 10.1093/brain/awv393.

PubMed [citation]
PMID:
26917586
PMCID:
PMC4766378

Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy.

Cullup T, Kho AL, Dionisi-Vici C, Brandmeier B, Smith F, Urry Z, Simpson MA, Yau S, Bertini E, McClelland V, Al-Owain M, Koelker S, Koerner C, Hoffmann GF, Wijburg FA, ten Hoedt AE, Rogers RC, Manchester D, Miyata R, Hayashi M, Said E, Soler D, et al.

Nat Genet. 2013 Jan;45(1):83-7. doi: 10.1038/ng.2497. Epub 2012 Dec 9.

PubMed [citation]
PMID:
23222957
PMCID:
PMC4012842
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003442589.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with Vici syndrome (PMID: 26917586). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg786Glufs*10) in the EPG5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EPG5 are known to be pathogenic (PMID: 23222957, 23674064).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024